Rene Bernards is a board member at Lixte Biotechnology Holdings, Inc. and holds the title of senior staff scientist at The Netherlands Cancer Institute. Bernards is also a co-founder of Oncosence and Oncosense BV, as well as the Chief Scientific Officer at Agendia. Additionally, Bernards is a professor of Molecular Carcinogenesis at Universiteit Utrecht and has extensive experience in cancer genetics research, molecular biology, and discovery oncology.
Sign up to view 0 direct reports
Get started